| Authors: |
Liu J; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Gonzalez-Hunt CP; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Richbourg T; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Barraza I; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Chen C; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Montes C; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Ma L; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Cao R; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Hanumaihgari V; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA., Gassman NR; Department of Pathology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, 35294, USA., Fouquerel E; UPMC Hillman Cancer Center, Department of Pharmacology and Chemical Biology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, 15232, USA., Sanders LH; Departments of Neurology and Pathology, Duke University School of Medicine, Durham, North Carolina, 27710, USA.; Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, North Carolina, 27710, USA. |
